French pharmaceutical giant Sanofi has seen its US$8.5 billion portfolio of older, off-patent drugs draw interest from private-equity firms KKR, Blackstone Group and TPG Capital, Bloomberg reported, c ...More
EJ Insight2014-07-25
Global investment fund KKR has all the signs of being bullish about China. Shortly after the company struck a US$140 million deal with China Modern Dairy (01117.HK) to farm cattle, KKR agreed to buy a ...More
EJ Insight2013-10-02
